Top Markets
Coin of the day
Lexaria Bioscience Corp. Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXW
Peringkat dalam Saham #41277
Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation... Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
Harga Saham
$0.0012
Terakhir disinkronkan: 2026-01-13
Kapitalisasi Pasar
$29.83K
Perubahan (1 hari)
-77.36%
Perubahan (1 tahun)
-98.91%
Negara
US
Perdagangan Lexaria Bioscience Corp. (LEXXW)

Kategori

Pendapatan untuk Lexaria Bioscience Corp. (LEXXW)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari Lexaria Bioscience Corp., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Lexaria Bioscience Corp. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE